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Introduction
During cell migration, the protrusive leading edge plays a key 
role in directional movement (Ridley et al., 2003). The leading 
edge of the migrating cells consists of the two types of actin 
cytoskeletal architectures, lamellipodia and fi  lopodia. Filopodia 
is the structure protruding from the edge of the cells that plays 
an essential role in the wide range of cell motile activities, 
including cancer cell migration (Wicki et al., 2006; Bennett 
et al., 2007) and neuronal path fi  nding (Lewis and Bridgman, 
1992; Bentley and O’Connor, 1994). Although many studies 
have been conducted on the role of actin-binding proteins in the 
actin dynamics at membrane protrusion (Nakagawa et al., 2003; 
Biyasheva et al., 2004; Lebrand et al., 2004), little is known 
about the role of the actin-based motor protein myosin in fi  lo-
podia formation.
Recent studies have revealed that myosin-X (myoX) has 
an important role in the elongation of fi  lopodia (Berg and 
Cheney, 2002; Tokuo and Ikebe, 2004; Zhang et al., 2004; Sousa 
and Cheney, 2005; Bohil et al., 2006; Bennett et al., 2007; 
Zhu et al., 2007). The N-terminal domain of myoX functions as 
a motor domain, which is followed by a neck region. The pre-
dicted coiled-coil segment is present at the C-terminal side of 
the neck region (Berg et al., 2000). However, a recent study sug-
gested that this domain does not form a stable coiled coil 
but instead forms a stable α helix (SAH; Knight et al., 2005). 
The C-terminal end of the molecule is the tail domain that was 
reported as a binding portion to the specifi  c cargo molecules 
(Tokuo and Ikebe, 2004; Weber et al., 2004; Zhang et al., 2004; 
Zhu et al., 2007). Because myoX moves toward the tip of fi  lo-
podia and transports the cargo molecules, the function of myoX 
was thought to simply be that of a cargo carrier.
In this study, we report that the motor activity of myoX is 
itself critical for the initiation of fi  lopodia formation. Using the 
inducible dimer-forming technique, we found that dimer forma-
tion of myoX without the cargo-binding domain can trigger the 
initiation of microspikes/fi  lopodia in lamellipodia in living 
cells. Furthermore, the elimination of myoX abolished the actin 
bundles and microspikes in lamellipodia, and the dimerized 
myoX can move laterally at the leading edge of lamellipodia. 
These fi  ndings suggest that the motor activity of myoX plays a 
role in the convergence of actin fi  bers in lamellipodia, thus 
forming the base for the initiation of fi  lopodia.
The motor activity of myosin-X promotes actin 
ﬁ  ber convergence at the cell periphery to initiate 
ﬁ  lopodia formation
Hiroshi Tokuo,
1 Katsuhide Mabuchi,
2 and Mitsuo Ikebe
1
1Department of Physiology, University of Massachusetts Medical School, Worcester, MA 01655
2Muscle Research Group, Boston Biomedical Research Institute, Watertown, MA 02472
F
ilopodia are actin-rich ﬁ  ngerlike protrusions found 
at the leading edge of migrating cells and are be-
lieved to play a role in directional sensing. Previous 
studies have shown that myosin-X (myoX) promotes ﬁ  lo-
podia formation and that this is mediated through its ability 
to deliver speciﬁ  c cargoes to the cell periphery (Tokuo, H., 
and M. Ikebe. 2004. Biochem Biophys. Commun. 319:214–
220; Zhang, H., J.S. Berg, Z. Li, Y. Wang, P. Lang, A.D. 
Sousa, A. Bhaskar, R.E. Cheney, and S. Stromblad. 2004. 
Nat. Cell Biol. 6:523–531; Bohil, A.B., B.W. Robertson, 
and R.E. Cheney. 2006. Proc. Natl. Acad. Sci. USA. 
103:12411–12416; Zhu, X.J., C.Z. Wang, P.G. Dai, Y. Xie, 
N.N. Song, Y. Liu, Q.S. Du, L. Mei, Y.Q. Ding, and W.C. 
Xiong. 2007. Nat. Cell Biol. 9:184–192). In this study, we 
show that the motor function of myoX and not the cargo 
function is critical for initiating ﬁ  lopodia formation. Using 
a dimer-inducing technique, we ﬁ  nd that myoX lacking its 
cargo-binding tail moves laterally at the leading edge of 
lamellipodia and induces ﬁ  lopodia in living cells. We con-
clude that the motor function of the two-headed form of 
myoX is critical for actin reorganization at the leading edge, 
leading to ﬁ  lopodia formation.
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Results and discussion
Dimerization with proper neck length 
is critical for the ﬁ  lopodial tip localization 
of myoX
To eliminate the effect of the tail-binding molecules on fi  lo-
podia formation, we constructed a GFP-tagged tailless myoX 
(Fig. 1). We produced constructs having the stable two-headed 
structure because that structure is necessary for continuous 
movement of the processive myosins (Veigel et al., 2002; Yildiz 
et al., 2003; Park et al., 2006). We added the coiled-coil domain 
of myosin-Va (myoV) at the C-terminal end of the SAH domain 
of myoX (Fig. 1 A, b). GFP signals of this construct showed 
a distinct localization at the tip of filopodia in COS7 cells 
(Fig. 1 A, b). Interestingly, the construct lacking the SAH domain 
(Fig. 1 A, a) failed to show the tip localization, although it 
formed the two-headed structure. On the other hand, GFP-
M10MoIQ3SAH and GFP-M10MoIQ3, having no stable coiled-
coil domain, failed to localize at the tip (unpublished data). 
These results suggest that the formation of the two-headed 
structure and the presence of the SAH domain are required for 
the movement of myoX toward the tip of fi  lopodia.
The regulated dimerization system of myoX
To further elucidate the relationship between the dimer formation 
of myoX and the initiation of fi  lopodia in the living cells, 
we used the regulated homodimerization system (described in 
Materials and methods). In the NIH3T3 cells expressing GFP-
M10MoIQ3SAH–FK506-binding protein (FKBP), GFP signals 
were distributed throughout the cell body (Fig. 1 B, a). After the 
addition of the homodimerizer AP20187, GFP signals became 
distinctly concentrated at the tip of fi  lopodia (Fig. 1 B, b). In con-
trast, GFP-M10MoIQ3SAH, having no FKBP domain, did not 
show the AP20187-induced tip localization (unpublished data). 
When we used the heterodimerizer AP21967 as a control, GFP-
M10MoIQ3SAH-FKBP did not localize at the tip (unpublished 
data). These results further support the notion that dimer forma-
tion is critical for the movement of myoX to the tip of fi  lopodia.
Induction of microspikes/ﬁ  lopodia by 
dimerization of tailless myoX
To further investigate the potential role of the monomer to dimer 
transition of myoX in fi  lopodia initiation, we performed quan-
tifi  cation of microspikes/fi  lopodia in COS7 cells (Fig. 1 C). 
The production of microspikes/fi  lopodia of GFP-M10MoIQ3SAH-
M5CC was four- to fi  vefold greater than that of GFP-M10MoIQ3-
M5CC (Fig. 1 C). Furthermore, addition of the dimerizer 
considerably induced the microspike formation in GFP-
M10MoIQ3SAH-FKBP–expressed cells, and the number of 
microspikes was four- to fi  vefold greater than without dimerizer 
(Fig. 1 C). These results suggest that the initiation of microspikes/
fi  lopodia takes place with the dimer formation of myoX.
Motor function and proper length of the 
lever arm of myoX
The aforementioned results indicate that three domains (motor, IQ, 
and SAH) of myoX are essential for the induction of fi  lopodia. 
It was hypothesized that the motor activity of myoX plays a critical 
role in the induction of fi  lopodia. To address this idea, we produced 
the two constructs having motor-dead mutation in switch I 
(R220A) or switch II (G437A) of GFP-M10MoIQ3SAH-FKBP. 
These two mutations were found to inhibit both the localization of 
myoX at the tip of fi  lopodia and the induction of fi  lopodia even 
after the addition of dimerizer (Fig. 2 A). These results support a 
critical role for the motor activity of myoX in fi  lopodia formation.
It has been proposed that the SAH domain may function as 
part of the myoX lever (Knight et al., 2005). To investigate a cor-
relation between the neck length and fi  lopodia formation, we con-
structed the myoX vectors that have different neck lengths by 
introducing a different number of IQs from myoV (Fig. 2 B).
The introduction of one IQ domain from myoV to the SAH-deleted 
construct (Fig. 2 B, a) considerably (four- to fi  vefold) increased the 
initiation of microspikes, and the expressed molecules were con-
centrated at the tip of fi  lopodia (unpublished data). There was no 
difference in the number of microspike/fi  lopodia between the con-
structs having one or two additional IQs (Fig. 2 C). The addition of 
even more IQs (M5(456), M5(3456), and M5(23456)) did not fur-
ther increase the number of microspikes (unpublished data).
It was reported that myosin-VIIa (myoVII) also has a SAH 
domain in the predicted coiled-coil region (Knight et al., 2005). 
To investigate whether the function of the SAH domain of 
myoX (M10SAH) is caused by the specifi  city of the M10SAH 
structure, we swapped M10SAH for M7SAH of the original 
construct (Fig. 2 B, c). The swapped construct induced the 
microspike/fi  lopodia after the addition of dimerizer, similar to 
the original construct (Fig. 2 C). It was calculated that the length 
of the SAH domain used in this study was  5.4 nm, and one IQ 
domain was 3.5 nm (Knight et al., 2005). Based on this calcula-
tion, the lengths of three IQs and a SAH (Fig. 1 A, b), four IQs 
without the SAH (Fig. 2 B, a), and fi  ve IQs without the SAH 
(Fig. 2 B, b) were 15.9 nm, 14.0 nm, and 17.5 nm, respectively. 
These results suggest that deletion of the SAH hampered the 
proper movement of myoX because of the lack of suffi  cient neck 
length. The results also indicate that it is important for myoX 
movement to have the certain minimum neck length. Therefore, 
it is likely that the SAH domain provides enough span and 
fl  exibility for myoX heads to search for the proper binding sites 
on actin fi  laments.
Dimerizer-induced formation of the 
two-headed structure of myoX
To examine whether AP20187 actually induces dimer formation 
in the cells, we expressed myc-M10MoIQ3SAH-FKBP along 
with GFP-M10MoIQ3SAH-FKBP-HA in COS7 cells (Fig. 3 A). 
The cells cotransfected with the aforementioned two constructs 
were incubated with or without AP20187. The myoX construct 
immunoprecipitated with anti-HA antibodies was recognized 
by both anti-myc and anti-HA antibodies only when the cells 
were incubated with AP20187 (Fig. 3 B, lane 4). The result 
indicates that AP20187 induces the dimer formation of 
M10MoIQ3SAH-FKBP in cells. It should be noted that the 
dimer formation of the same construct was not detected with 
AP21967 (unpublished data). To directly visualize the structure 
of the molecules of the myoX constructs, the isolated myoX DIMERIZATION OF MYOSIN-X INDUCES FILOPODIA • TOKUO ET AL. 231
Figure 1.  Dimerization with proper neck length of myoX is critical for ﬁ  lopodia formation. (A) Localization of the tailless myoX constructs franked with the 
coiled-coil domain of myoV. COS7 cells were transfected with GFP-M10MoIQ3-M5CC (a) or GFP-M10MoIQ3SAH-M5CC (b) and stained with rhodamine-
phalloidin (red). Arrow indicates GFP-M10MoIQ3SAH-M5CC at the tip of ﬁ  lopodium. (B) The myoX constructs with the homodimerization domain induced 
ﬁ  lopodia formation upon addition of the dimerizer. NIH3T3 cells were transfected with GFP-M10MoIQ3SAH-FKBP (green) and replated on FN for 3 h with 
100 nM AP20187. Red indicates rhodamine-phalloidin staining. Arrow indicates GFP-M10MoIQ3SAH-FKBP at the tip of ﬁ  lopodium. (C) Quantiﬁ  cation of 
microspikes/ﬁ  lopodia. Microspikes/ﬁ  lopodia per 20 μm of the cell leading edge were counted in COS7 cells untransfected or transfected with the indi-
cated constructs. The frequency of microspikes/ﬁ  lopodia was increased signiﬁ  cantly by the addition of an SAH domain to M10MoIQ3 or forced dimeriza-
tion with the SAH domain (P < 0.001). Error bars represent the mean ± SD. Bars, 10 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  232
molecules were subjected to electron microscopic observation. 
Approximately 70% of the molecules of M10MoIQ3SAH-
FKBP were two headed in the presence of AP20187, whereas 
all of the molecules were monomeric in the absence of AP20187 
(Fig. 3 C). These results clearly show that AP20187 induces the 
two-headed structure of M10MoIQ3SAH-FKBP.
The tailless myoX induces ﬁ  lopodia upon 
dimerization in living cells
Using the induced dimerization technique described in Fig. 1 B, 
we examined whether the formation of the two-headed struc-
ture of myoX directly related to the initiation of fi  lopodia in 
the living cells. The representative images of spreading cells 
Figure 2.  The motor activity and neck length of myoX is essential for ﬁ  lopodia initiation. (A) Localization of two different kinds of motor-dead myoX con-
structs of GFP-M10MoIQ3SAH-FKBP. COS7 cells were transfected with R220A mutant (top) or G437A mutant (bottom) and stained with rhodamine-phalloidin 
(red). (B) Schematic showing GFP-tagged constructs with different neck domains. (C) Quantiﬁ  cation of microspikes/ﬁ  lopodia. Microspikes/ﬁ  lopodia were 
counted as described in Fig. 1. The frequency of microspikes/ﬁ  lopodia was increased signiﬁ  cantly by the addition of one or two IQ domains of myoV to 
M10MoIQ3-M5CC or forced dimerization with myoVII’s SAH domain. Error bars represent the mean ± SD. The asterisk indicates a signiﬁ  cant difference 
(P < 0.001) in comparison with cells expressing GFP-M10MoIQ3-M5CC (Fig. 1 A, a). Bars, 10 μm.DIMERIZATION OF MYOSIN-X INDUCES FILOPODIA • TOKUO ET AL. 233
plated on the fi  bronectin (FN)-coated coverslip are shown in 
Fig. 4 A and Video 1 (available at http://www.jcb.org/cgi/content/
full/jcb.200703178/DC1). Before the addition of the dimerizer, 
GFP-M10MoIQ3SAH-FKBP showed diffuse localization through-
out the cytosol, and fewer than three of the fl  uorescent puncta 
(the tip of fi  lopodia) per cell appeared from the cell periphery 
Figure 3.  The two-headed structure of myoX is induced by dimerizer. (A) Schematic drawing of the dimerization of myc-M10MoIQ3SAH-FKBP with GFP-
M10MoIQ3SAH-FKBP-HA induced by the dimerizing agent AP20187. (B) Dimer formation of myoX revealed by Western blot analysis. The experiment was 
performed as described in Materials and methods. (C) The rotary shadowing images of the one-headed and two-headed tailless myoX. (top) M10MoIQ3SAH-
FKBP-GFP puriﬁ  ed from the cells without AP20187. (bottom) M10MoIQ3SAH-FKBP-GFP puriﬁ  ed from the cells in the presence of AP20187. The galleries 
illustrate the range of appearances of double-headed molecules showing the narrow-opened parallel (top) dimers, the wide-opened parallel (middle) dimers, 
and the antiparallel dimers (bottom). Bar, 5 nm.JCB • VOLUME 179 • NUMBER 2 • 2007  234
(Fig. 4 A, arrowhead). After the addition of the dimerizer, >20 
additional fl  uorescent puncta appeared within 7 min (Fig. 4 A, 
bottom). Note that the induced new fi  lopodia were produced 
only from the active ruffl  ing area and quickly retracted to the 
edge (Video 1).
Fig. 4 B and Video 2 (available at http://www.jcb.org/cgi/
content/full/jcb.200703178/DC1) show representative images 
of the migrating cells on the FN-coated coverslip. The cell 
shown in Fig. 4 B and Video 2 was observed migrating from 
the bottom to the top of the frame (Fig. 4 B, arrow). Before 
the addition of AP20187 (Fig. 4 B, top), substantial accumula-
tion of GFP-M10MoIQ3SAH-FKBP at the leading edge was 
observed, and the predominant structure of the leading edge 
was lamellipodia. Approximately 3 min after the addition of 
AP20187, several short fi  lopodia appeared from the leading 
edge and elongated in the direction of the migration (Fig. 4 B, 
bottom). However, the short fi  lopodia retracted quickly to the 
edge of lamellipodia. The protrusion and retraction of the fi  lo-
podia continued while the cell was moving forward. It should 
be noted that newly produced fi  lopodia only protruded from 
the leading edge but never appeared from the lateral or the rear 
side of the migrating cells (Video 2). In contrast, AP21967 
had no inducible effect on the production of fi  lopodia (unpub-
lished data).
It was also discovered that after the addition of AP20187, 
GFP-M10MoIQ3SAH-FKBP moved laterally along the leading 
edge and fused with another tip of fi  lopodia (Fig. 4 C and 
Video 3, available at http://www.jcb.org/cgi/content/full/jcb
.200703178/DC1). It should be emphasized that the lateral 
movement was not observed before addition of the dimerizer. 
Lateral movement of the full-length myoX has been reported 
using another cell line (Sousa et al., 2006). The present re-
sults suggest that the tail domain is not necessary for the lateral 
movement of myoX along the leading edge of lamellipodia and 
that formation of the two-headed structure is critical not only 
for intrafi  lopodial movement but also for lateral movement at 
the leading edge.
Knockdown of the expression of myoX
To further clarify the function of myoX in fi  lopodia formation, 
experiments were conducted to eliminate the expression of 
endogenous myoX, and the effect of the deletion of myoX in ac-
tin dynamics was examined. The myoX-specifi  c siRNA   markedly 
reduced the expression of myoX as revealed by both Western 
blotting (Fig. S1 A) and immunocytochemistry (Fig. S1 B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200703178/DC1). 
In control double-stranded RNA–treated cells, the endogenous 
myoX localized at the tips of detectable actin fi  laments (bundles) 
that are aligned radially at the leading edge in lamellipodium. 
The elimination of myoX abolished not only the myoX localiza-
tion at the tip of lamellipodia but also the radial arrangement 
of actin bundles at the cell periphery (Fig. S1 B). We also used 
pSIREN-DNR-DsRed plasmid that coexpresses small hairpin 
RNA (shRNA) and DsRed simultaneously to monitor the trans-
fected cells. Two target sequences were used as a control: mouse 
specifi  c (siM10m) and human specifi  c (siM10h; Fig. S1 C). 
3 d after the transfection, immunostaining showed that the 
expression of siM10m but not siM10h shRNAs markedly de-
creased levels of myoX in mouse NIH3T3 cells (Fig. S1 D). 
It should be noted that siM10m showed an effect on the actin 
structure similar to myoX-specifi  c siRNA (Fig. 5 A).
To evaluate the specifi  city of the myoX knockdown pheno-
type, we performed rescue experiments. GFP-tagged bovine myoX 
(GFP-M10MoIQ3SAH-FKBP) that is refractory to siM10m 
shRNA restored microspike formation in cells expressing siM10m 
shRNA after the addition of AP20187 (Fig. 5, A and B; rescue). 
On the other hand, GFP-M10F also restored the formation of 
protrusion from lamellipodium. However, actin bundles were 
elongated to the long fi  lopodia (unpublished data), which is 
consistent with a previous study showing that the full-length 
myoX induces long, stable fi  lopodia (Berg and Cheney, 2002). 
These results indicate that the siRNA effect is specifi  c to the 
loss of myoX but not as a result of off-target silencing. These 
results support the idea that myoX is important for promoting 
fi  lopodia initiation in lamellipodia.
Based on these results, we propose the following model 
(Fig. 5 C). (1) MyoX is present as a dimer and monomer in the 
cells. The monomeric (single headed) myoX does not localize 
at the edge of lamellipodia. (2) Once the dimer is produced, 
myoX moves to the tip of the actin fi  laments, presumably as a 
result of its ability to walk on the actin fi  laments toward the 
barbed end. (3) The tips move laterally along the leading edge 
with actin fi  laments, and the mechanical activity of myoX plays 
a role in this process. (4) The lateral movement of myoX con-
vergences on the barbed end of the actin fi  laments, thus produc-
ing the base of fi  lopodia where the actin polymerization system 
might gather to induce parallel actin bundles.
According to the convergent elongation model of fi  lo-
podia formation, the initiation step of fi  lopodia consists of actin 
fi  lament convergence and the barbed-end interaction in lamelli-
podia (Svitkina et al., 2003). We think that the lateral movement 
of dimerized myoX powers these movements and the structural 
changes of actin cytoskeleton in the lamellipodia. The function 
of the SAH domain can be related to the step size of myoX 
or the fl  exibility of the neck domain to search for an appropri-
ate binding site on an actin protofi  lament. It has been reported 
that the shortening of the neck length of myoV markedly dimin-
ishes the run length (Purcell et al., 2002). Because the neck 
length (the number of IQ motifs) of myoX is one half of myoV, 
it is thought that the SAH domain functions to help myoX to 
fi  nd the proper actin monomer in the fi  lament, thus facilitating 
the continuous movement.
Although the tailless myoX can initiate fi  lopodia forma-
tion, the fi  lopodia produced are short and unstable. These results 
suggest that the tail portion of myoX is important for the elon-
gation and stabilization of fi  lopodia and that these processes are 
likely to be controlled by the cargo molecules binding to the tail 
of myoX. Recently, it was reported that the unconventional 
myosin myosin-VI is dimerized after binding to Disabled-2 or 
the lipids phosphatidylinositol 4,5-disphosphate (Spudich et al., 
2006). The pleckstrin homology domain of myoX also binds 
to the lipid phosphatidylinositol 3,4,5-trisphosphate in vitro 
(Tacon et al., 2004). Thus, it is possible that the dimer formation 
of myoX is induced by lipid binding. The tail domains of myoX DIMERIZATION OF MYOSIN-X INDUCES FILOPODIA • TOKUO ET AL. 235
have binding partners such as microtubules (Weber et al., 2004), 
integrins (Zhang et al., 2004), and VASP (vasodilator- stimulated 
phosphoprotein; Tokuo and Ikebe, 2004). It is plausible that 
these binding proteins also control the dimer formation of 
myoX. Understanding the spatio-temporal regulation of the 
monomer-dimer transition of myoX in cells is a critical problem 
requiring further study.
Materials and methods
Plasmid construction
The construction of expression vector GFP-M10F was described previously 
(Tokuo and Ikebe, 2004). The cDNA encoding the ﬁ  rst 811 amino acids, 
including the motor domain and the three IQ motifs, was ampliﬁ  ed by PCR 
and subcloned in frame to pEGFP-C1 (pEGFP-M10MoIQ3). Inclusion of 
the SAH domain (the ﬁ  rst 861 amino acids) was also constructed using 
the same method (pEGFP-M10MoIQ3SAH). The sequence of the coiled-coil 
Figure 4.  The tailless myoX induces ﬁ  lopodia in the lamellipodia upon dimerization. Time-lapse imaging shows the movement of GFP-M10MoIQ3SAH-
FKBP in living COS7 cells. The numbers on the images indicate time (minutes/seconds) after the addition of 100 nM AP20187 to the culture medium. 
In the spreading cell (A) and in the migrating cell (B), GFP shows the localization of M10MoIQ3SAH-FKBP. The arrowhead in A shows that a ﬁ  lopodium 
existed before the addition of dimerizer. The arrow in B shows the moving direction of the cell. (C) Some ﬂ  uorescent puncta (arrows) move laterally along 
the leading edge and fuse with another tip of ﬁ  lopodia (arrowheads). Bars (A and B), 10 μm; (C) 5 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  236
Figure 5.  MyoX is essential for ﬁ  lopodia induction from lamellipodia. (A) Rescue of the knockdown phenotype by myoX. Fewer ﬁ  lopodia are seen in cells 
transfected with the knockdown construct (siM10m) compared with the control (siM10h). A cell expressing both siM10m shRNA and GFP-M10MoIQ3-SAH-
FKBP (rescue) displays numerous microspikes after the addition of 100 nM AP20187. Asterisks show microspikes/ﬁ  lopodia. (B) Quantiﬁ  cation of micro-
spikes/ﬁ  lopodia. Microspikes/ﬁ  lopodia in NIH3T3 cells transfected with the indicated constructs were counted as described in Fig. 1. The frequency of 
microspikes/ﬁ  lopodia was decreased signiﬁ  cantly by transfection with knockdown construct (P < 0.001). Error bars represent the mean ± SD. (C) Model 
of ﬁ  lopodia initiation upon the formation of the two-headed myoX. (1) MyoX is present as both a dimer and a monomer in the cells. The monomeric (single 
headed) myoX is present throughout the cytosol. (2) Once myoX forms the two-headed structure, myoX moves to the tips of the actin ﬁ  laments, presumably DIMERIZATION OF MYOSIN-X INDUCES FILOPODIA • TOKUO ET AL. 237
region of mouse myoV (M5CC; 907–1,090 amino acids) was ampliﬁ  ed 
by PCR and fused to the aforementioned expression vectors (pEGFP-
M10MoIQ3-M5CC and pEGFP-M10MoIQ3SAH-M5CC). Using the same 
methods, IQ6 to the coiled-coil region (885–1,090 amino acids) or IQ5 to 
the coiled-coil region (863–1,090 amino acids) was fused to pEGFP-
M10MoIQ3 to create pEGFP-M10MoIQ3-M5(6)-M5CC and pEGFP-
M10MoIQ3-M5(56)-M5CC, respectively.
Regulated dimerization system
Based on human FKBP and its small molecular ligands (Mallet et al., 2002), 
an FKBP was fused to the C-terminal end of the SAH domain of myoX (GFP-
M10MoIQ3SAH-FKBP). The membrane-permeable drug created by chemi-
cal cross-linking of the two monomeric ligands with short linker (AP20187) 
can speciﬁ  cally bind to FKBP. If two FKBPs are present, AP20187 binds to 
both FKBPs, thus creating a dimer of the targeting molecule. As a control, 
we used AP21967, a chemically modiﬁ  ed derivative of rapamycin that 
can induce the heterodimerization of FKBP and FRB-containing fusion pro-
teins. To create pEGFP-M10MoIQ3-FKBP and pEGFP-M10MoIQ3SAH-
FKBP, a fragment encoding FKBP was isolated from pC4-Fv1E (provided by 
ARIAD Pharmaceuticals) by restriction digestion and subcloned into pEGFP-
M10MoIQ3 and pEGFP-M10MoIQ3SAH. pEGFP-M10MoIQ3-M7SAH-
FKBP was created by swapping M10SAH for the rat myoVII SAH domain 
(M7SAH; 869–926 amino acids).
To determine the dimer formation by AP20187, COS7 cells were 
cotransfected with myc-M10MoIQ3SAH-FKBP and GFP-M10MoIQ3SAH-
FKBP-HA. 16 h after transfection, 100 nM AP20187 was added to the 
culture medium and incubated for 30 min. The cell lysates were subjected 
to immunoprecipitation with anti-HA antibody. The immunoprecipitated 
samples were subjected to SDS-PAGE followed by Western blotting with 
anti-HA and anti-myc antibodies.
Motor-dead construct
The sequence of the switch I loop (NNNSSRFG; residues 215–220) of 
myoX with the exception of the second N is conserved in all nearby myosins 
sequenced so far (Shimada et al., 1997). The R to A mutation in the switch I 
loop results in loss of the ATP binding ability of skeletal myosin-II (Li et al., 
1998) and the actin ﬁ  lament sliding activity of Dictyostelium discoideum 
myosin-II in the in vitro motility assay (Shimada et al., 1997). The motor do-
main of myoX also has a conserved sequence of the switch II loop (DIFGFE; 
residues 434–439) that has a charge interaction with switch I loop. This 
interaction is critical for ATP hydrolysis by myosin (Li et al., 1998). Although 
the G to A mutation in switch II does not abolish ATP binding to the active 
site, it causes the loss of ATP hydrolysis (Kambara et al., 1999) and actin 
sliding activity (Sasaki et al., 1998). According to the aforementioned results, 
we made two types of motor-dead constructs having a mutation in switch I 
(R220A) or in switch II (G437A) by site-directed mutagenesis (Kunkel, 1985, 
1987) of pEGFP-M10MoIQ3SAH-FKBP (Fig. 2 A).
Cell culture and transfection
African green monkey kidney COS7 cells and NIH3T3 ﬁ  broblasts (Ameri-
can Type Culture Collection) were cultured in DME supplemented with 10% 
FCS. Transient transfections were performed with Fugene-6 (Roche Bio-
chemicals) or LipofectAMINE 2000 (Invitrogen) according to the manufac-
turer’s instructions. At 16 h after transfection, cells were trypsinized and 
replated on FN for 3 h, ﬁ  xed, and stained with rhodamine-phalloidin.
Immunoﬂ  uorescence microscopy
Immunoﬂ  uorescence microscopy was performed as described previously 
(Tokuo and Ikebe, 2004). In brief, cells were cultured on 10 μg/ml FN-
coated coverslips ﬁ  xed with 4% formaldehyde, 2 mM MgCl2, and 1 mM 
EGTA in PBS for 10 min at RT, treated with 0.2% Triton X-100 in PBS for 
5 min, and washed with PBS. Blocking was performed by incubating the 
ﬁ  xed cells with 5% BSA in PBS for 60 min at RT. After the antibodies had 
been diluted with the blocking solution, the cells were incubated at 4°C 
overnight with the primary antibody and subsequently for 30 min with the 
secondary antibody. For actin staining, AlexaFluor phalloidin (Invitrogen) 
was added to the secondary antibody. Specimens were observed at RT 
using a laser-scanning confocal microscope (DM IRB; Leica) controlled 
by a confocal microscope system (TCS SP II; Leica) equipped with a 
Plan-Apochromat 60× 1.40 NA oil immersion objective (Leica) with appro-
priate binning of pixels and exposure time. The images were processed 
using Photoshop 7.0 software (Adobe). Immunoﬂ  uorescence video micros-
copy was imaged using the same system of immunoﬂ  uorescence to control 
illumination shutters and camera exposure (Leica). Time-lapse images were 
obtained by sequential epiﬂ  uorescent and phase illumination. The intervals 
were 10 s, and exposure times were 100–300 ms depending on the time-
lapse interval and level of ﬂ  uorescence. Cells were imaged over periods of 
1–30 min at room temperature (25–30°C). Video ﬁ  les were created using 
QuickTime (Apple).
Quantiﬁ  cation of microspikes/ﬁ  lopodia
Spread cells containing prominent lamella with leading edges were chosen 
from phalloidin-stained samples. The number of actin bundles touching 
(microspike) or crossing (ﬁ  lopodium) the edge was counted. Only bundles 
that have ﬂ  uorescence intensity of at least 1.2 times above the background 
were considered. Data were analyzed using a t test. 50 cells (Figs. 1 C 
and 2 C) and 20 cells (Fig. 5 B) were quantiﬁ  ed for each sample. For the 
rescue experiments, analysis of the number of microspikes/ﬁ  lopodia used 
cells expressing GFP-M10MoIQ3SAH-FKBP.
Immunoprecipitation and Western blotting analysis
Cells were lysed in lysis buffer (20 mM Hepes, pH 7.4, 150 mM NaCl, 
2 mM MgCl2, 0.2 mM EGTA, 1 mM ATP, 0.5% NP-40, 1 mM PMSF, 10 μg/ml 
leupeptin, 2 μg/ml pepstatin A, and 1 μg/ml trypsin inhibitor). The sam-
ples were centrifuged at 10,000 g for 20 min at 4°C, and the supernatants 
were incubated with antibodies conjugated to Afﬁ  -Prep Protein A (Bio-Rad 
Laboratories) for 2 h at 4°C. The precipitates were washed ﬁ  ve times in 
ice-cold lysis buffer. The precipitates were dissolved in 5% SDS and 0.5 M 
NaHCO3 buffer. These samples were then subjected to Western blotting as 
described previously (Tokuo and Ikebe, 2004).
Recombinant protein and electron microscopy
M10-MoIQ3SAH-FKBP-GFP was subcloned into pFastBac-HT baculovirus 
transfer vector (Invitrogen) containing a hexa-His-tag. The recombinant M10-
MoIQ3SAH-FKBP-GFP protein was copuriﬁ   ed with calmodulin as reported 
previously (Homma and Ikebe, 2005) with an additional incubation with or 
without 100 nM AP20187 (ARIAD Pharmaceuticals) for 30 min at RT before 
the cell lysis step. Rotary metal-shadowing electron microscopy of M10-
MoIQ3SAH-FKBP-GFP was performed as described previously (Li et al., 
2006). In brief, myoX proteins diluted to  4 nM were absorbed onto a freshly 
cleaved mica surface for 30 s. Unbound proteins were rinsed away, and the 
specimen was stabilized by brief exposure to uranyl acetate as described pre-
viously (Mabuchi, 1990). The specimen was visualized by the rotary shadow-
ing technique according to a previously described method (Mabuchi, 1991) 
with an electron microscope (model 300; Philips) at 60 kV.
siRNA experiments
The mouse myoX Stealth siRNA (target sequence 5′-G  G  A  U  G  U  C  G  G  G  C  U  G-
A  U  U  G  A  U  U  C  U  G  U  A  -3′ corresponding to nt 4,011–4,035 relative to the start 
codon) was generated by Invitrogen. Control siRNA was purchased from 
Dharmacon. pSIREN-DNR-DsRed-siM10h and -siM10m were constructed 
according to the manufacturer’s instructions (BD Biosciences). The selected 
target sequences for siM10h was nt 135–153 of human myoX (GenBank/
EMBL/DDBJ accession no. AF_234532) and for siM10m was nt 135–153 
of mouse myoX (GenBank/EMBL/DDBJ accession no. NM_019472). 
siM10h and siM10m had three base mismatches; thus, siM10h served as 
a negative control of siM10m. The rescue construct (GFP-M10MoIQ3-
SAH-FKBP) made from bovine myoX had four base mismatches to siM10m 
and were refractory to siM10m siRNA. The siRNA and plasmid transfection 
were performed using LipofectAMINE 2000 (Invitrogen) according to the 
manufacturer’s instructions. The cells were analyzed 3 d after transfection.
Online supplemental material
Fig. S1 shows the depletion of myoX in NIH3T3 cells. Video 1 shows the 
movement of tailless myoX (GFP-M10-MoIQ3SAH-FKBP) in a spreading 
COS7 cell. Video 2 shows the movement of tailless myoX in a migrating 
COS7 cell. Video 3 shows lateral movement of the tailless myoX along the 
leading edge of a migrating cell upon addition of the dimerizer. Online 
as a result of its ability to walk on the actin ﬁ  laments toward the barbed end. (3) The tips of the actin ﬁ  laments move laterally along the leading edge, with 
the motor function of myoX playing a role in this process. (4) The lateral drift induces a convergence of the barbed ends of the actin ﬁ  laments, thus inducing 
the formation of microspikes. Bars, 5 μm.JCB • VOLUME 179 • NUMBER 2 • 2007  238
supplemental material is available at http//www.jcb.org/cgi/content/
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